GB Patent

GB0523576D0 — Drug composition and its use in therapy

Assigned to Vectura Group PLC · Expires 2005-12-28 · 20y expired

What this patent protects

Patent listed against chembl-chembl34259.

Drugs covered by this patent

chembl-chembl34259 (METHOTREXATE)

Patent Metadata

Patent number: GB0523576D0
Jurisdiction: GB
Classification: —
Expires: 2005-12-28
Drug substance claim: No
Drug product claim: No
Assignee: Vectura Group PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.